SBI Securities’s Biomerica BMRA Stock Holding History

SBI Securities’s Portfolio BMRA Stock Details BMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2	Closed	-$5	–	4038
2025 Q4	$5	Hold	2	–	–	﹤0.01%	3928
2025 Q3	$6	Hold	2	–	–	﹤0.01%	4082
2025 Q2	$6	Sell	2 -1	-33%	-$4	﹤0.01%	4052
2025 Q1	$11	Buy	+3	New	+$15	﹤0.01%	3948

Other funds holding BMRA

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

HCM

Hollencrest Capital Management Newport Beach, California $1.54B AUM 30.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

MCF Advisors Covington, Kentucky $2.8B AUM 19.11% 1-Year Est. Return

SBI Securities's BMRA Position: Q1 2026 in Review

SBI Securities sold out of Biomerica (BMRA) in Q1 2026, closing a stake of 2 shares — an estimated $5 sold.

SBI Securities first reported a position in BMRA in Q1 2025 and held it in 4 quarters. The position peaked at $11 in Q1 2025. 11 funds tracked by Wall St. Rank hold BMRA as of Q1 2026.

SBI Securities reported no remaining Biomerica position as of Q1 2026 after selling out during the quarter.
SBI Securities sold 2 Biomerica shares in Q1 2026, an estimated $5.
SBI Securities first reported a position in Biomerica in Q1 2025 and held it in 4 quarters.
SBI Securities's Biomerica position peaked at $11 in Q1 2025.
11 funds tracked by Wall St. Rank held Biomerica as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.